Thank you. That's very good to know, and a very worthwhile effort and philosophy. Thank you for promoting this approach.
This question is for Dr. Fowke. I'm a graduate of the University of Manitoba, so thank you for coming. We talked about the different steps of research. When you find a new drug, you have the biomedical discovery. You find this molecule. It does this, and it could be useful, but developing it into a drug requires the very expensive process of a randomized clinical trial, which is to somewhat allude to what Dr. Yusuf had said about population-based research.
I know you were talking about something different, Dr. Yusuf, when you said population-based research, but it involves very large populations. We understand that pharmaceutical companies are doing this research, and they want patents because they want a protection for all this money they spent.
If these randomized clinical trials were, in fact, performed or funded through public agencies, would this then take the burden off these companies that produced them to recoup the losses of development and lead to lower drug prices? Is there that potential if the public is funding the randomized clinical trials?